Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
clinical trials.
.
Show all posts
Showing posts with label
clinical trials.
.
Show all posts
Tuesday, March 24, 2015
Aptose begins APTO-253 clinical study in patients with relapsed or refractory hematologic malignancies
›
Description of APTO-253 (LOR-253): APTO-253, also known as LOR-253, LT-253, is a small molecule inhibitor of human metal-regulat...
›
Home
View web version
